ICU Medical Inc (ICUI) stock
Close on Nov 11, 2026Market cap $4.46BP/E 74.0Yield –
ICU Medical Inc saw revenue fall 5.9% to $2.18B over the twelve months to Sep 30, 2026. Operating income rose 47.8% to $110.66M, moving the operating margin from 3.2% to 5.1%. Free cash flow was $208.60M, up 189.9% from a year earlier. At the latest close the market valued the company at $4.46B, 74.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $4.46B
- P/E ratio
- 74.0
- Price to sales
- 2.04
- Price to book
- 2.03
- Dividend yield
- –
- Free cash flow yield
- 4.68%
Fundamentals
- Revenue
- $2.18B
- Net income
- $60.33M
- EPS, diluted
- $2.41
- Free cash flow
- $208.60M
- Book value per share
- $87.15
- Diluted shares
- 25M
Trading
- Next earnings
- Feb 18, 2027 (estimated, during market hours)
- Previous close
- $182.11
- Open
- $180.26
- Day's range
- $173.10 – $182.22
- Volume
- 299,198
- Average volume (20 days)
- 276,331
- Index membership
- S&P SmallCap 600 (since Nov 2023), Russell 2000 (since Sep 2024), Russell 3000
- Beta (5 years)
- 1.00
- 52-week range
- $113.37 – $192.85
- RSI (14 days)
- 61.5
- Volatility (1 year)
- 35.6%
- Relative volume
- 1.10×
- WACC
- 9.2%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ICUI | S&P 500 | Difference | ICUI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +11.2% | -2.4% | +13.6 pts | ||
| 3 months | -2.1% | -1.2% | −0.9 pts | ||
| Year to date | +24.9% | +12.3% | +12.7 pts | ||
| 1 year | +24.5% | +12.4% | +12.0 pts | ||
| 3 years | +117.6% | +78.8% | +38.8 pts | +29.6% | +21.4% |
| 5 years | -26.4% | +75.2% | −101.6 pts | -6.0% | +11.9% |
| 10 years | +23.5% | +311.1% | −287.6 pts | +2.1% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases ICU Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About ICU Medical
Surgical & Medical Instruments & Apparatus
ICU Medical, Inc. develops, manufactures, and sells medical devices and products used in infusion therapy, vascular access, and vital care settings. The company operates through business units that include Consumables, Infusion Systems, and Vital Care. Its offerings encompass ambulatory, syringe, and large volume infusion pumps, safety software, dedicated and non-dedicated IV sets, needlefree connectors, vascular access catheters, closed system transfer devices, tracheostomy tubes, temperature management systems, hemodynamic monitoring devices, and regional anesthesia products. ICU Medical provides these solutions primarily to acute care hospitals, wholesalers, ambulatory clinics, and alternate site care facilities, including outpatient centers and long-term care providers.
Company profile, executives and historyICU Medical stock: common questions
What is ICU Medical's stock price?
ICUI closed at $178.26 on Nov 11, 2026, down 2.11% on the day. Over the past 52 weeks it traded between $113.37 and $192.85.
What is ICU Medical's market cap?
ICU Medical was worth $4.46B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ICUI's P/E ratio?
ICUI trades at 74.0 times earnings, based on diluted earnings per share of $2.41 over the twelve months to Sep 30, 2026.
How much revenue does ICU Medical make?
ICU Medical reported revenue of $2.18B for the twelve months to Sep 30, 2026, down 5.9% from a year earlier.
Does ICU Medical pay a dividend?
No. ICU Medical has not paid a cash dividend over the last twelve months.
When does ICU Medical report earnings next?
ICU Medical is expected to report Q4 FY2026 results on Feb 18, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has ICUI stock performed over the past year?
Including dividends, ICUI returned +24.5% over the past year, against +12.4% for the S&P 500.
How many ICUI shares are sold short?
2M shares were sold short at the latest FINRA report, 6.81% of the float, or 8.0 days of average trading volume.
Who are ICU Medical's competitors?
Companies most similar to ICU Medical by business, industry and size include TFX, MMSI, PEN, MMED, IART.
See a number that looks wrong?